Intuitive Surgical, Inc. $ISRG Shares Sold by Foundations Investment Advisors LLC

Foundations Investment Advisors LLC trimmed its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 62.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,021 shares of the medical equipment provider’s stock after selling 1,694 shares during the quarter. Foundations Investment Advisors LLC’s holdings in Intuitive Surgical were worth $578,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Draper Asset Management LLC increased its position in shares of Intuitive Surgical by 41.9% during the fourth quarter. Draper Asset Management LLC now owns 5,029 shares of the medical equipment provider’s stock worth $2,848,000 after acquiring an additional 1,485 shares during the period. Atlantic Union Bankshares Corp increased its position in shares of Intuitive Surgical by 19.3% during the third quarter. Atlantic Union Bankshares Corp now owns 22,759 shares of the medical equipment provider’s stock worth $10,179,000 after acquiring an additional 3,676 shares during the period. AGF Management Ltd. increased its position in shares of Intuitive Surgical by 0.6% during the third quarter. AGF Management Ltd. now owns 464,179 shares of the medical equipment provider’s stock worth $207,595,000 after acquiring an additional 2,575 shares during the period. Procyon Advisors LLC increased its position in shares of Intuitive Surgical by 787.8% during the fourth quarter. Procyon Advisors LLC now owns 4,794 shares of the medical equipment provider’s stock worth $2,715,000 after acquiring an additional 4,254 shares during the period. Finally, Oppenheimer Asset Management Inc. increased its position in shares of Intuitive Surgical by 29.3% during the fourth quarter. Oppenheimer Asset Management Inc. now owns 71,077 shares of the medical equipment provider’s stock worth $40,255,000 after acquiring an additional 16,119 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Intuitive Surgical

In related news, SVP Mark Brosius sold 645 shares of Intuitive Surgical stock in a transaction on Monday, March 9th. The shares were sold at an average price of $485.01, for a total transaction of $312,831.45. Following the sale, the senior vice president directly owned 1,613 shares in the company, valued at $782,321.13. This trade represents a 28.57% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Myriam Curet sold 105 shares of Intuitive Surgical stock in a transaction on Tuesday, March 10th. The stock was sold at an average price of $493.95, for a total transaction of $51,864.75. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 4,833 shares of company stock valued at $2,357,582 over the last quarter. 0.60% of the stock is owned by insiders.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG opened at $412.26 on Tuesday. The company’s fifty day moving average price is $452.19 and its 200 day moving average price is $504.81. Intuitive Surgical, Inc. has a 12 month low of $411.83 and a 12 month high of $603.88. The firm has a market capitalization of $146.01 billion, a P/E ratio of 49.97, a P/E/G ratio of 3.39 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 EPS for the quarter, topping the consensus estimate of $2.08 by $0.42. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The firm had revenue of $2.77 billion for the quarter, compared to analyst estimates of $2.62 billion. During the same period last year, the business earned $1.81 EPS. Intuitive Surgical’s revenue for the quarter was up 23.0% compared to the same quarter last year. On average, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 8.57 EPS for the current year.

Wall Street Analysts Forecast Growth

ISRG has been the topic of a number of recent research reports. Raymond James Financial cut their price objective on Intuitive Surgical from $615.00 to $577.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 22nd. BTIG Research reaffirmed a “buy” rating and set a $574.00 price objective on shares of Intuitive Surgical in a research report on Wednesday, April 22nd. Argus cut their price objective on Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating on the stock in a research report on Wednesday, February 4th. Truist Financial cut their price objective on Intuitive Surgical from $650.00 to $580.00 and set a “buy” rating on the stock in a research report on Wednesday, April 15th. Finally, TD Cowen cut their price objective on Intuitive Surgical from $660.00 to $585.00 and set a “buy” rating on the stock in a research report on Wednesday, April 22nd. Nineteen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $576.71.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.